These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 165002)

  • 1. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
    Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
    Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth increments with low dose intermittent growth hormone and fluoxymesterone in first year of therapy in hypopituitarism.
    Kirkland RT; Clayton GW
    Pediatrics; 1979 Mar; 63(3):386-8. PubMed ID: 220585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
    J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
    Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
    Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
    Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
    Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthetic human growth hormone: current status and future questions.
    Thompson RG; Conforti P; Holcombe J
    J Endocrinol Invest; 1989; 12(8 Suppl 3):35-9. PubMed ID: 2809097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypopituitarism with recombinant somatropin for 1 year.
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Acta Paediatr Scand Suppl; 1988; 347():169-75. PubMed ID: 3254031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to treatment with pituitary growth hormone: the New Zealand experience.
    Livesey JH; Cuneo RC; Donald RA; Harris RG; Ibberston HK; Costello JM; Holdaway IM; Gluckman PD; Fraser TR; Chapman GE
    N Z Med J; 1989 Aug; 102(873):399-402. PubMed ID: 2761875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of children with short stature.
    O'Shea D; Byrne M; Powell D
    Ir Med J; 1990 Mar; 83(1):25-7. PubMed ID: 2361835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose single weekly injections of growth hormone: response during first year of therapy of hypopituitarism.
    Rosenbloom AL; Riley WJ; Silverstein JH; Garnica AD; Netzloff ML; Weber FT
    Pediatrics; 1980 Aug; 66(2):272-6. PubMed ID: 7402812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment with human growth hormone in children with pituitary insufficiency under 7 years of age. Study of 26 cases].
    Mugnier E; Ployard F; Roy MP; Fermanian J; Rappaport R
    Arch Fr Pediatr; 1985 Oct; 42(8):671-6. PubMed ID: 4074096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Authentic recombinant human growth hormone. Results of a multicenter clinical trial in patients with growth hormone deficiency.
    Rasmussen LH; Zachmann M; Nilsson P
    Helv Paediatr Acta; 1989 Jun; 43(5-6):443-8. PubMed ID: 2663792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone.
    Lippe BM; Van Herle AJ; LaFranchi SH; Uller RP; Lavin N; Kaplan SA
    J Clin Endocrinol Metab; 1975 Apr; 40(4):612-8. PubMed ID: 165211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone treatment for short stature.
    Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
    N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delay of constitutional development--studies on therapy with growth hormone].
    Butenandt O
    Klin Padiatr; 1984; 196(2):69-72. PubMed ID: 6737950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of constitutional delay of growth and adolescence with human growth hormone.
    Bierich JR
    Klin Padiatr; 1983; 195(5):309-16. PubMed ID: 6632708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey.
    Job JC; Chaussain JL; Garnier P; Rolland A; Joab N
    Acta Paediatr Scand Suppl; 1987; 337():93-105. PubMed ID: 3481186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
    Sulmont V; Brauner R; Fontoura M; Rappaport R
    Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.